Pre and Post-Hemodialysis Cerebral Blood Flow Velocity in Patients With End-Stage Renal Disease.

Hale Zeynep Batur ÇağlayanYasemin ErtenAsli Akyol GursesCeyla IrkecBijen Nazliel

Published in: The neurologist (2023)

Compensatory cerebral autoregulation and chronic adjustment to therapy may be the reason for the nondeviation of the CBFV values from normality observed in both sessions.

Keyphrases

cerebral blood flow
end stage renal disease
chronic kidney disease
peritoneal dialysis
blood flow
stem cells
drug induced
mesenchymal stem cells
replacement therapy
bone marrow
cell therapy